SUTRO BIOPHARMA, INC. License Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Exclusive License Agreement between Sutro Biopharma, Inc. and Ipsen Pharma SAS (March 29, 2024)
License Agreements
SUTRO BIOPHARMA, INC.
Biotechnology
CA
2024
Amendment to License Agreement between Sutro Biopharma, Inc. and Tasly Biopharmaceuticals Co., Ltd.
License Agreements
SUTRO BIOPHARMA, INC.
Biotechnology
2022
License Agreement between Sutro Biopharma, Inc. and Tasly Biopharmaceuticals Co., Ltd. (December 20, 2021)
License Agreements
SUTRO BIOPHARMA, INC.
Biotechnology
NY
2022
Option and License Agreement between BioNova Pharmaceuticals Limited and Sutro Biopharma, Inc.
License Agreements
SUTRO BIOPHARMA, INC.
Biotechnology
NY
2022
Second Amendment to Exclusive Patent License and Research Collaboration Agreement between Sutro Biopharma, Inc. and Merck Sharp & Dohme Corp.
License Agreements
SUTRO BIOPHARMA, INC.
Biotechnology
2021
Exclusive Patent License and Research Collaboration Agreement between Sutro Biopharma, Inc. and Merck Sharp & Dohme Corp.
License Agreements
SUTRO BIOPHARMA, INC.
Biotechnology
NY
2018
Amended and Restated Exclusive License Agreement between Stanford University and Fundamental Applied Biology, Inc.
License Agreements
SUTRO BIOPHARMA, INC.
Biotechnology
CA
2018
Amended and Restated Collaboration and License Agreement among Celgene Corporation, Celgene Alpine Investment Company II, LLC, and Sutro Biopharma, Inc.
License Agreements
SUTRO BIOPHARMA, INC.
Biotechnology
NY
2018
License Agreement between Sutro Biopharma Inc. and Merck KGaA for Antibody-Drug Conjugate Technology
License Agreements
SUTRO BIOPHARMA, INC.
Biotechnology
UT
2018